Diet appears to reduce growth rate in prostate cancer
Researchers report that a diet low in omega-6 and high in omega-3 fatty acids, combined with fish oil supplements has led to a reduced growth rate of prostate… read more.
Researchers report that a diet low in omega-6 and high in omega-3 fatty acids, combined with fish oil supplements has led to a reduced growth rate of prostate… read more.
Researchers report that, among patients with high-risk smoldering multiple myeloma, treatment with daratumumab appears to be associated with a significantly lower risk of progression to active multiple myeloma… read more.
Lung cancer screening with low-dose chest computed tomography (CT) has the potential to detect coronary artery calcium too, researchers reported on Dec. 2, 2024 in the CMAJ (Canadian Medical Association… read more.
Researchers report that an injection of benralizamab administered during some attacks of asthma and COPD, is significantly more effective than current standard treatment with steroid tablets. The findings… read more.
Researchers from the SUMMIT trial have reported that treatment with tirzepatide has reduced the risk of worsening heart failure and cardiovascular disease-related death for obese adults. The findings… read more.
Patients treated with an anticoagulant drug have a doubled risk of internal bleeding if they also use a non-steroidal anti-inflammatory painkilling drug (NSAID) such as ibuprofen, diclofenac or… read more.
Adding treatment with pembrolizumab to standard of care in patients with advanced soft tissue sarcoma of the limb appears to significantly improve disease-free survival, researchers reported on Nov…. read more.
Researchers report that the number of people in the U.S. who died from ischemic heart disease related to obesity increased by approximately 180% from 1999 to 2020. The… read more.
Young people diagnosed with severe obesity who had weight-loss surgery at age 19 or younger have achieved sustained weight loss 10 years later, researchers reported on Oct. 30,… read more.
One treatment with a CRISPR-Cas9 based gene editing therapy, NTLA-2002, could replace daily medication of many patients with hereditary angioedema (HAE), a painful condition with severe onset of… read more.
Researchers report that patients treated with semaglutide have achieved a significantly lower risk of developing Alzheimer’s disease compared to those exposed to seven other anti-diabetic medications, including other… read more.
An investigative immunotherapy regimen for advanced Hodgkin lymphoma has increased the survival rate from 80 percent to 92 percent, researchers reported on Oct. 17, 2024 in the NEJM/New… read more.
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.